Christenson L K, Osborne T F, McAllister J M, Strauss J F
Center for Research on Reproduction and Women's Health, University of Pennsylvania (L.K.C., J.F.S.), Philadelphia, Pennsylvania 19104.
Endocrinology. 2001 Jan;142(1):28-36. doi: 10.1210/endo.142.1.7867.
The steroidogenic acute regulatory protein (StAR) gene controls the rate-limiting step in the biogenesis of steroid hormones, delivery of cholesterol to the cholesterol side-chain cleavage enzyme on the inner mitochondrial membrane. We determined whether the human StAR promoter is responsive to sterol regulatory element-binding proteins (SREBPs). Expression of SREBP-1a stimulated StAR promoter activity in the context of COS-1 cells and human granulosa-lutein cells. In contrast, expression of SREBP-2 produced only a modest stimulation of StAR promoter activity. One of the SREBP-1a response elements in the StAR promoter was mapped in deletion constructs and by site-directed mutagenesis between nucleotides -81 to -70 from the transcription start site. This motif bound recombinant SREBPs in electrophoretic mobility shift assays, but with lesser affinity than a low density lipoprotein receptor SREBP-binding site. An additional binding site for the transcriptional modulator, yin yang 1 (YY1), was observed within the SREBP-binding site (nucleotides -73 to -70). Mutation of the YY1-binding site increased the responsiveness of the StAR promoter to exogenous SREBP-1a, but did not alter the affinity for SREBP-1a binding in electrophoretic mobility gel shift assays. Manipulations that altered endogenous mature SREBP-1a levels (e.g. culture in lipoprotein-deficient medium and addition of 27-hydroxycholesterol) did not affect StAR promoter function, but influenced low density lipoprotein receptor promoter activity. We conclude that 1) the human StAR promoter is conditionally responsive to SREBP-1a such that promoter activity is up-regulated in the presence of high levels of SREBP-1a, but is unaffected when mature SREBP levels are suppressed; and 2) the human StAR promoter is selectively responsive to SREBP-1a.
类固醇生成急性调节蛋白(StAR)基因控制着类固醇激素生物合成中的限速步骤,即将胆固醇转运至线粒体内膜上的胆固醇侧链裂解酶。我们确定了人类StAR启动子是否对固醇调节元件结合蛋白(SREBPs)有反应。在COS-1细胞和人颗粒黄体细胞中,SREBP-1a的表达刺激了StAR启动子活性。相比之下,SREBP-2的表达仅对StAR启动子活性产生适度刺激。通过缺失构建体和对转录起始位点上游-81至-70核苷酸之间进行定点诱变,确定了StAR启动子中的一个SREBP-1a反应元件。在电泳迁移率变动分析中,该基序与重组SREBPs结合,但亲和力低于低密度脂蛋白受体SREBP结合位点。在SREBP结合位点(核苷酸-73至-70)内观察到转录调节因子阴阳1(YY1)的另一个结合位点。YY1结合位点的突变增加了StAR启动子对外源SREBP-1a的反应性,但在电泳迁移率凝胶变动分析中未改变对SREBP-1a结合的亲和力。改变内源性成熟SREBP-1a水平的操作(如在缺乏脂蛋白的培养基中培养和添加27-羟基胆固醇)不影响StAR启动子功能,但影响低密度脂蛋白受体启动子活性。我们得出结论:1)人类StAR启动子对SREBP-1a有条件反应,即在高水平SREBP-1a存在时启动子活性上调,但在成熟SREBP水平被抑制时不受影响;2)人类StAR启动子对SREBP-1a有选择性反应。